PharmaSynergy-Rx

The Event

PharmaSynergyRx is known for creating a focused and tailored event that caters to companies pursuing co-development, partnerships, licensing, and commercial deals.
The event always goes beyond the ordinary, offering a comprehensive programme that includes Business Development-tuned content, opportunities for informal networking, and structured B2B meetings.
Now in its 8th year, PharmaSynergyRx has solidified its position as a premier Rx-focused partnering event for both global and regional companies.

What to Expect

Clear Product Portfolio Focus

  • Primary, Niche, Branded, and Hybrid Generics
  • Value-Added Medicines (VAMs)
  • Specialty, Biosimilars
  • Legacy Products and NCEs
  • Platforms: Dosage, Formulation, Delivery

1-2-1 Meetings & Networking


Your pre-scheduled time slots and content sessions are seamlessly woven into the fabric of the day, ensuring that your agenda is personalised, leaving no room for missed opportunities.

BD&L Tuned Content


We aim to provide diverse perspectives and strategic insights. In 2027, the event will feature compelling speakers discussing strategies, BD&L and portfolio approaches, geo opportunities and international partnerships.

Event Audience

Over two days, we bring together BD&L executives and company owners from North and South America, APAC, MENA, and Europe. The focus is: fresh perspectives, new market opportunities, and meaningful, Rx-portfolio-driven conversations.

The event is built for connections. You will meet new faces, have real conversations, and make multiple introductions through planned sessions and spontaneous moments alike – over coffee, during talks, and at evening cocktail.
Below is a snapshot of the companies that attend the Rx edition.

Partnering Platform

Join PharmaSynergy-Rx

Join us in London for 2 days of productive meetings and meaningful discussions.